News & Updates
Filter by Specialty:

Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant
Treatment with sotrovimab does not appear to confer protection against severe forms of COVID-19 in a setting dominated by the Omicron BA.2 subvariant, a study has found.
Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant
26 Sep 2022
Elobixibat affords metabolic benefits in type 2 diabetes
In type 2 diabetes (T2D) patients with constipation, treatment with elobixibat alleviates constipation while improving glucose metabolism and lowering serum low-density lipoprotein cholesterol (LDL-C) and arachidonic acid (AA) levels, according to the results of a single-arm pilot study.
Elobixibat affords metabolic benefits in type 2 diabetes
25 Sep 2022
Does frozen embryo transfer up hypertension risk during pregnancy?
The risk of hypertensive disorders in pregnancy (HDP) is increased following assisted reproductive technology (ART) using frozen embryo transfer (FET) compared with after fresh embryo transfer or natural conception, according to results of a study presented at ESHRE 2022.
Does frozen embryo transfer up hypertension risk during pregnancy?
25 Sep 2022
Late-life overweight, obesity may protect against Alzheimer’s
Body mass index in later adulthood appears to be inversely correlated with the incidence of Alzheimer’s disease (AD), a recent study has found. Older adults who are overweight or obese see lower AD risks.